Long Noncoding RNAs (lncRNAs) as Biomarkers of Prognosis in TNBC and Non-TNBC Breast Cancer Patients
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177617 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Marcio Luis Acencio und 13 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Core Unit, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, L-4362 Esch-sur-Alzette, Luxembourg. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Biomarkers, Tumor, Triple Negative Breast Neoplasms, Breast Neoplasms. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, FIC NIH HHS, Susan G. Komen Breast Cancer Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Functional studies have shown that long noncoding RNAs (lncRNAs) play different roles in gene expression regulation, acting as epigenetic factors. Accumulating evidence indicates that lncRNAs modulate diverse biological processes, and their altered expression is associated with the development and progression of cancer, including BC. Here, aiming to identify lncRNAs associated with breast cancer, we performed a re-analysis of the expression data from 1071 tumors of eligible patients in the LACRN-MPBC Study. Using normalized data, we compared the expression profiles of triple-negative breast cancer (TNBC; 170 cases) and a heterogeneous group of non-TNBC tumors (782 cases). A total of 59 differentially expressed lncRNAs (DELncRNAs) could be identified based on the criteria of |log2FC| ≥ 1 and FDR < 0.05, using the DESeq2 R package. In the Kaplan–Meier survival analysis, we identified DELncRNAs that affect disease-free survival and/or overall survival, with eight of them in TNBC and 27 in non-TNBC patients. Multivariate Cox proportional-hazards models were used to evaluate independent predictors of survival. Two DELncRNAs, VLDLR-AS1 and PART1, were identified as independent prognostic markers for TNBC patients, while seven (LINC00239, FAM30A, LINC00842, LINC01315, EGOT, LY6E-DT, and SLC25A21-AS1) were independent prognostic markers for non-TNBC patients. Our computational study identifies several candidate lncRNAs associated with clinical outcomes in breast cancer. However, the DELncRNAs identified here should be interpreted as preliminary candidates, which require future validation and functional studies to determine their biological roles and evaluate their potential as prognostic biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioinformatics Core Unit, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, L-4362 Esch-sur-Alzette, Luxembourg.
- Centro de Investigação Translacional em Oncologia-CTO, Instituto do Câncer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), Avenida Doutor Arnaldo, 251, 8° Floor, Sao Paulo 012…
- Comprehensive Center for Precision Oncology, Universidade de Sao Paulo, Avenida Doutor Arnaldo, 251, 8° Floor, Sao Paulo 01246-000, SP, Brazil.
- Clinical and Functional Group, Centro Internacional de Pesquisa (CIPE), AC Camargo Cancer Center, Sao Paulo 01508-010, SP, Brazil.
- Molecular and Cellular Therapy Laboratory, Fundación Instituto Leloir-CONICET, Buenos Aires C1405BWE, Argentina.
- Bone Marrow Transplantation Unit, Instituto Nacional de Câncer, Rio de Janeiro 20230-130, RJ, Brazil.
ORCID-Profile: Marcio Luis Acencio, Xinhui Wang, Flavia R Rotea Mangone, Andrea S Llera, Eliana S F W Abdelhay, Nora Artagaveytia, Eduardo Moraes Reis, Roger Chammas, Carlos Velazquez, Maria A Nagai
Förderung
- NCI NIH HHS
- FIC NIH HHS
- Susan G. Komen Breast Cancer Foundation
- Ministry of Health
- Global Health at the United States- National Cancer Institute at the National Institutes of Health
- Fogarty International Center
- Susan G. Komen for the Cure
- Fundación Argentina de Nanotecnología at the Ministry of Science, Technology, and Innovation
Zitieren
APA
Acencio, M. L., Wang, X., Mangone, F. R. R., Carraro, D. M., Llera, A. S., Abdelhay, E. S. F. W., Artagaveytia, N., Daneri-Navarro, A., Reis, E. M., Sanches, L., Chammas, R., Podhajcer, O. L., Velazquez, C., & Nagai, M. A. (2026). Long Noncoding RNAs (lncRNAs) as Biomarkers of Prognosis in TNBC and Non-TNBC Breast Cancer Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177617
Vancouver
Acencio ML, Wang X, Mangone FRR, Carraro DM, Llera AS, Abdelhay ESFW, et al. Long Noncoding RNAs (lncRNAs) as Biomarkers of Prognosis in TNBC and Non-TNBC Breast Cancer Patients. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177617
BibTeX
@article{Acencio2026,
author = {Acencio, Marcio Luis and Wang, Xinhui and Mangone, Flavia R Rotea and Carraro, Dirce Maria and Llera, Andrea S and Abdelhay, Eliana S F W and Artagaveytia, Nora and Daneri-Navarro, Adrian and Reis, Eduardo Moraes and Sanches, Leonardo and Chammas, Roger and Podhajcer, Osvaldo L and Velazquez, Carlos and Nagai, Maria A},
title = {Long Noncoding RNAs (lncRNAs) as Biomarkers of Prognosis in TNBC and Non-TNBC Breast Cancer Patients},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177617}
}
EUVIMED